Flossbach Von Storch »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Flossbach Von Storch

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Flossbach Von Storch from 13F filings

Historical chart of Flossbach Von Storch investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Flossbach Von Storch consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Flossbach Von Storch

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5M 2.5M 0.98
2023-12-31 $2.4M 2.5M 0.94
2023-09-30 $2.4M 2.5M 0.94

More positions owned by Flossbach Von Storch

Berkshire Hathaway (BRK.B)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Danaher Corporation (DHR)
Apple (AAPL)
Charles Schwab Corporation (SCHW)
Abbott Laboratories (ABT)
Johnson & Johnson (JNJ)
Fortive (FTV)
Amphenol Corporation (APH)
Intercontinental Exchange (ICE)
Pepsi (PEP)
Visa (V)
Thermo Fisher Scientific (TMO)

View all positions for Flossbach Von Storch

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS
Readystate Asset Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1